Globalization. Serialization. Clinical trials. Cold chain operations. Custom drug protocols. Compliance. Risk Management. Corporate Social Responsibility (CSR). First pass yield. Over the last decade, the number and variety of supply chain initiatives exploded for the pharmaceutical leader. As a result, the supply chain group, and the business imperatives, grew in importance.
Overall, the pharmaceutical supply chain fared better through the decade than that of consumer products or food/beverage. The reason? The pharmaceutical supply chain entered the decade as a supply chain laggard. They were able to focus and catch up to the level of other industries. In this report we discuss the trends driving these results and what pharma companies must know to prepare for the next decade of competition.
